Model Number 4540014 |
Device Problem
Excess Flow or Over-Infusion (1311)
|
Patient Problems
Nausea (1970); Malaise (2359)
|
Event Date 11/14/2023 |
Event Type
malfunction
|
Event Description
|
As reported by the user facility information by bbm sales organization in ukraine: "over infusion".According to the complainant, an oncological patient was undergoing chemotherapy treatment.The drug, fluorouracil - 4440 milligrams (mg) per 88.8 milliliters (ml) and sodium chloride 0.9% (388 ml), was introduced into the pump and administered to the patient.The patient returned home before the end of the infusion, and after completion, returned to the clinic for further treatment.Reportedly, the infusion completed twelve (12) hours earlier, and the patient complained about the rapid end of the infusion.The patient was noted as having nausea and general malaise.
|
|
Manufacturer Narrative
|
This report has been identified as b.Braun internal report number (b)(4).A follow-up report will be provided after the examination results are available.Note: this report is being filed for an item number that is not sold in the united states, however similar items are sold in the united states by b.Braun medical, inc.
|
|
Manufacturer Narrative
|
This report has been identified as b.Braun medical internal report number (b)(4).Root cause analysis: device history record (dhr): reviewed the dhr for batch 22b18gea71 with article 4540014-20, there is no abnormality and no such defect detected at in process and at final control inspection.Sample/s evaluation: the flow rate report of affected batch 22b18gea71 was reviewed.For final control flow rate (after eto) report, the average flow rate deviation from the nominal flow rate was between (b)(4).Received 1 used and filled easypump ii lt 400-40-s-cis.As received condition, the clamp clip of received sample was clamped, and no wing cap was connected to the patient connector.Visual inspection had done throughout the received sample.No abnormality was observed.The sample was decontaminated and sent for flow rate test ((b)(4)).The flow rate deviation from nominal flow rate for received sample was (b)(4).The flow rate of received sample was within the specification (b)(4) deviation from nominal flow rate.Summary of root cause analysis: since the flow rate of received sample was within the specification, hence we considered this complaint as not confirmed.Cause : cause could not be determine.The flow rate of received sample was within the specification after sent for flow rate test, which is according to test method (b)(4) under lab condition.Justification: not confirmed.This report is being filed for an item number that is not sold in the united states, however similar items are sold in the united states by b.Braun medical, inc.
|
|
Search Alerts/Recalls
|
|